Mad analysis of FHIT, a putative human tumor suppressor from the HIT protein family

Structure

Volumn 5, Issue 6, 1997, Pages 763-774

  Lima, Christopher D ^a   D'Amico, Kevin L ^b   Naday, Istvan ^b   Rosenbaum, Gerold ^b   Westbrook, Edwin M ^b   Hendrickson, Wayne A ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b ARGONNE NATIONAL LABORATORY   (United States)

Author keywords

Advanced photon source; HIT protein family; PKCl; Tumor suppresser; X ray crystallography

Indexed keywords

EID: 0031570668     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(97)00231-1     Document Type: Article

References (57)

1. Seraphin, B. (1992). The HIT protein family: a new family of proteins present in prokaryotes, yeast and mammals. J. DNA Seq. Map. 3, 177-179.
2. Robinson, K. & Aitken, A. (1994). Identification of a new protein family which includes bovine protein kinase C inhibitor-1. Biochem. J. 304, 662-664.
3. Lima, C.D., Klein, M.G., Weinstein, I.B. & Hendrickson, W.A. (1996). Three-dimensional structure of human protein kinase C interacting protein 1, a member of the HIT family of proteins. Proc. Natl. Acad. Sci. USA 93, 5357-5362.
4. Brenner, C., et al., & Lowenstein, J.M. (1997). Crystal structures of HINT demonstrate that histidine triad proteins are GalT-related nucleotide-binding proteins. Nat. Struct. Biol. 4, 231-238.
5. Ohta, M., et al., & Huebner, K. (1996). The FHIT gene, spanning chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84, 587-597.
6. Sozzi, G., et al., & Croce, C.M. (1996). The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell 85, 17-26.
7. Sozzi, G., et al., & Croce, C.M. (1996). Aberrant FHIT transcripts in Merkel cell carcinoma. Cancer Res. 56, 2472-2474.
8. Negrini, M., et al., & Croce, C.M. (1996). The FHIT gene at 3p14.2 is abnormal in breast carcinoma. Cancer Res. 56, 3173-3179.
9. Virgilio, L., et al., & Croce, C.M. (1996). FHIT gene alterations in head and neck squamous cell carcinomas. Proc. Natl. Acad. Sci. USA 93, 9770-9775.
10. Panagopoulos, I., et al., & Åman, P. (1996). The FHIT and PTPRG genes are detected in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14. Cancer Res. 56, 4871-4875.
11. Mao, L., Fan, Y.-H., Lotan, R. & Hong, W.K. (1996). Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. Cancer Res. 56, 5128-5131.
12. Shridhar, R., et al., & Smith, D.I. (1996). Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors. Cancer Res. 56, 4347-4350.
13. Yanagisawa, K., et al., & Takahashi, T. (1996). Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines. Cancer Res. 56, 5579-5582.
14. Druck, T., et al., & Huebner, K. (1997). Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res. 57, 504-507.
15. Gartenhaus, R.B. (1997). Allelic loss determination in chronic lymphocytic leukemia by immunomagnetic bead sorting and microsatellite marker analysis. Oncogene 14, 375-378.
16. Thiagalingam, S., et al., & Vogelstein, B. (1996). Evaluation of the FHIT gene in colorectal cancers. Cancer Res. 56, 2936-2939.
17. Geurts, J.M.W., Schoenmakers, E.F.P.M., Roijer, E., Stenman, G. & Van de Ven, J.M. (1997). Expression of reciprocal hybrid transcripts of HMGIC and FHIT in a pleomorphic adenoma of the parotid gland. Cancer Res. 57, 13-17.
18. 4A) hydrolase from Schizosaccharomycespombe. Biochem. Biophys. Acta 1161, 139-148.
19. McLennan, A.G. (1992). Ap4A and Other Dinucleoside Polyphosphates. CRC Press.
20. Barnes, L.D., et al., & Huebner, K. (1996). FHIT, a putative tumor suppressor in humans, is a dinucleoside 5′,5‴-P1,P3-triphosphate hydrolase. Biochemistry 36, 11529-11535.
21. Hendrickson, W.A. (1991). Determination of macromolecular structures from anomalous diffraction of synchrotron radiation. Science 254, 51-58.
22. Hendrickson, W.A., Horton, J.R. & LeMaster, D.M. (1990). Selenomethionyl proteins produced for analysis by multiwavelength anomalous diffraction (MAD): a vehicle for direct determination of three-dimensional structure. EMBO J. 9, 1665-1672.
23. Westbrook, E. (1996). CCD-based area detectors. Methods Enzymol. 276, in press.
24. Shapiro, L., et al., & Hendrickson, W.A. (1995). Structural basis of cell-cell adhesion by cadherins. Nature 374, 327-337.
25. 1-ATPase. Acta Cryst. D 52, 30-42.
26. Jones, T.A., Zou, J.Y., Cowan, S.W. & Kjeldgaard, M. (1991). Improved methods for building protein models in electron density maps and the location of errors in these models. Acta. Cryst. A 47, 110-119.
27. Orengo, C.A. & Thornton, J.M. (1993). Alpha plus beta folds revisited: some favoured motifs. Structure 1, 105-120.
28. Nicholls, A., Sharp, K.A. & Honig, B.H. (1991). Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons. Prot. Struct. Funct. Genet. 11, 281-296.
29. Brzoska, P.M., et al., & Christman, M.F. (1995). The product of the ataxia-telangiectasia group D complementing gene, ATDC, interacts with a protein kinase C substrate and inhibitor. Proc. Natl. Acad. Sci. USA 92, 7824-7828.
30. Brzoska, P.M., et al., & Christman, M.F. (1996). Cloning, mapping, and in vivo localization of a human member of the PKCI-1 protein family (PRKCNH1). Genomics 36, 151-156.
31. Robinson, K., Jones, D., Howell, S., Soneji, Y., Martin, S. & Aitken, A. (1995). Expression and characterization of maize ZBP1 4, a member of a new family of zinc-binding proteins. Biochem. J. 307, 267-272.
32. 2+-binding proteins from bovine brain including a potent inhibitor of protein kinase C. Biochem. J. 232, 559-567.
33. MacDonald, J.R., Groschel-Stewart, U. & Walsh, M.P. (1987). Properties and distribution of the protein inhibitor (Mr 17,000) of protein kinase C. Biochem. J. 242, 695-705.
34. Pearson, J.D., et al., & Walsh, M.P. (1990). Amino acid sequence and characterization of a protein inhibitor of protein kinase C. J. Biol. Chem. 265, 4583-4591.
35. Fraser, E.D. & Walsh, M.P. (1991). The major endogenous bovine brain protein kinase C inhibitor is a heat-labile protein. FEBS Lett. 294, 285-289.
36. Mozier, N.M., Walsh, M.P. & Pearson, J.D. (1991). Characterization of a novel zinc binding site of protein kinase C inhibitor-1. FEBS Lett. 279, 14-18.
37. Holm, L. & Sander, C. (1997). New structure-novel fold? Structure 15, 165-171.
38. Holm, L. & Sander, C. (1997). Enzyme HIT? Trends Biochem. Sci. 22, 116-117.
39. Wedekind, JE., Frey, P.A. & Rayment, I. (1995). Three-dimensional structure of galactose-1-phosphate uridylyltransferase from Escherichia coli at 1.8Å resolution. Biochemistry 34, 11049-11061.
40. Wedekind, J.E., Frey, P.A. & Rayment, I. (1996). The structure of nucleotidylated histidine-166 of galactose-1-phosphate uridylyltransferase provides insight into phosphoryl group transfer. Biochemistry 35, 11560-11569.
41. Pilkis, S.M., Walderhaug, M., Murray, K., Beth, A., Venkataramu, S.D., Pilkis, J. & El-Maghrabi, M.R. (1983). 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase from rat liver. J. Biol. Chem. 258, 6135-6141.
42. Tauler, A., Lin, K. & Pilkis, S.J. (1990). Hepatic 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. J. Biol. Chem. 265, 15617-15622.
43. Lin, K., Li, L., Correia, J.J. & Pilkis, S.J. (1992). Glu327 is part of a catalytic triad in rat liver fructose-2,6-bisphosphatase. J. Biol. Chem. 267, 6556-6562.
44. Hasemann, C.A., Istvan, E.S., Uyeda, K. & Deisenhofer, J. (1996). The crystal structure of the bifunctional enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase reveals distinct domain homologies. Structure 4, 1017-1029.
45. Smith, R.H. & Johnson, K.S. (1988). Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67, 31-40.
46. Jankarik, J. & Kim, S.H. (1991). Sparse matrix sampling: a screening method for crystallization. J. Appl. Cryst. 24, 409-411.
47. Otwinowski, Z. (1993). Data collection and processing. In Proceedings of the CCP4 study weekend. (Sawyer, L., Isaccs, N. & Bailey, S. eds), pp. 56-62, SERC Daresbury Laboratory, Warrington, UK.
48. Westbrook, M.L, Coleman, T.A., Daley, R.T. & Pflugrath, J.W. (1996). Data acquisition and analysis at the Structural Biology Center. In Proceedings of IUCr Computing School, in press.
49. CCP4 SERC (UK). (1979). Collaborative Computing Project 4 Daresbury Laboratory, Warrington, UK.
50. Navaza, J. (1984). AMoRe: an automated package for molecular replacement. Acta. Cryst. A 50, 157-163.
51. Brunger, A.T., Kuriyan, J. & Karplus, M. (1987). Crystallographic R factor refinement by molecular dynamics. Science 235, 458-460.
52. Brunger, A.T. (1992). Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 355, 472-474.
53. Evans, S.V. (1993). SETOR: hardware lighted three-dimensional solid model representations of macromolecules. J. Mol. Graphics 11, 134-138.
54. 4A) asymmetrical hydrolase: sequence similarity with the histidine triad (HIT) protein family. Biochem. J. 312, 925-932.
55. Fleischmann, R.D., et al., & Venter, J.C. (1995). Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269, 496-512.
56. Bult, C.J., et al., & Venter, J.C. (1996). Complete genome sequence of the Methanococcus archaeon, Methanococcusjannaschii. Science 273, 1058-1073.
57. Bustos, S., Schaefer, M.R. & Golden, S.S. (1990). Different and rapid response of four cyanobacterial psbA transcripts to changes in light intensity. J. Bacteriol. 172, 1998-2004.